Counterclaims Nixed In Drug Price Checker's Antitrust Suit
A New York federal court has found the National Association of Boards of Pharmacy failed to show it was harmed by alleged false statements made by a drug price-checking website, tossing...To view the full article, register now.
Already a subscriber? Click here to view full article